Folx Health, a Boston, MA-based digital healthcare service provider designed for the medical needs of the LGBTQIA+ community, raised $25m in Series A financing.
The round was led by Bessemer Venture Partners with participation from existing investors Define Ventures and Polaris.
The company, which came out of stealth in December 2020, raising $4.4m in seed funding led by Polaris, intends to use the funds to drive national expansion and expand its offerings in sexual health and family creation later in 2021 and early 2022.
Led by A.G. Breitenstein, Founder and CEO, Folx Health is an LGBTQIA+ healthcare service provider built to serve the community’s specific needs. The company is also announcing the availability of its Hormone Replacement Therapy (HRT: testosterone or estrogen) and will also begin releasing its sexual health and wellness offerings starting with Erectile Dysfunction (ED) treatment, soon to be followed by at-home STI Testing and Treatment, all customized for the specifics of Queer and Trans bodies. All services will include unlimited on-demand clinical support with at-home lab testing (for most plans) and home-delivered medications (costs may vary based on medication). Upon launch, Folx Health is available in: CA, CT, DE, FL, IL, MA, NC, NY, TX, VA, WA.
The company is also launching the Folx Library, a content hub that will serve as a free resource for all things Queer and Trans health. The Library addresses questions and concerns ranging from an overview of the expected physical changes with HRT to how to navigate the health system.